Literature DB >> 17376907

Identification of Hendra virus G glycoprotein residues that are critical for receptor binding.

Kimberly A Bishop1, Tzanko S Stantchev, Andrew C Hickey, Dimple Khetawat, Katharine N Bossart, Valery Krasnoperov, Parkash Gill, Yan Ru Feng, Lemin Wang, Bryan T Eaton, Lin-Fa Wang, Christopher C Broder.   

Abstract

Hendra virus (HeV) is an emerging paramyxovirus capable of infecting and causing disease in a variety of mammalian species, including humans. The virus infects its host cells through the coordinated functions of its fusion (F) and attachment (G) glycoproteins, the latter of which is responsible for binding the virus receptors ephrinB2 and ephrinB3. In order to identify the receptor binding site, a panel of G glycoprotein constructs containing mutations was generated using an alanine-scanning mutagenesis strategy. Based on a predicted G structure, charged amino acids residing in regions that could be homologous to those in the measles virus H attachment glycoprotein known to be involved in its protein receptor interaction were targeted. Using a coprecipitation-based assay, seven single-amino-acid substitutions in HeV G were identified as having significantly impaired binding to both the ephrinB2 and ephrinB3 viral receptors: D257A, D260A, G439A, K443A, G449A, K465A, and D468A. The impairment of receptor interaction conferred a concomitant diminution in their abilities to promote membrane fusion when coexpressed with F. The G glycoprotein mutants were also recognized by three or more conformation-dependent monoclonal antibodies of a panel of five, were expressed on the cell surface, and retained their abilities to bind and coprecipitate F. Interestingly, some of these mutant G glycoproteins coprecipitated with F more efficiently than wild-type G. Taken together, these data provide strong biochemical and functional evidence that some of these residues could be part of a conformation-dependent, discontinuous, and overlapping ephrinB2 and -B3 binding domain within the HeV G glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376907      PMCID: PMC1900305          DOI: 10.1128/JVI.02022-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.

Authors:  Sompong Vongpunsawad; Numan Oezgun; Werner Braun; Roberto Cattaneo
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 2.  Viral glycoprotein-mediated cell fusion assays using vaccinia virus vectors.

Authors:  Katharine N Bossart; Christopher C Broder
Journal:  Methods Mol Biol       Date:  2004

Review 3.  Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly.

Authors:  Alexei Poliakov; Marisa Cotrina; David G Wilkinson
Journal:  Dev Cell       Date:  2004-10       Impact factor: 12.270

4.  The human CD46 molecule is a receptor for measles virus (Edmonston strain).

Authors:  R E Dörig; A Marcil; A Chopra; C D Richardson
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 5.  Structure and function of a paramyxovirus fusion protein.

Authors:  Trudy G Morrison
Journal:  Biochim Biophys Acta       Date:  2003-07-11

6.  Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.

Authors:  O Nussbaum; C C Broder; E A Berger
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.

Authors:  D Naniche; G Varior-Krishnan; F Cervoni; T F Wild; B Rossi; C Rabourdin-Combe; D Gerlier
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head.

Authors:  Nicolas Massé; Michelle Ainouze; Benjamin Néel; T Fabian Wild; Robin Buckland; Johannes P M Langedijk
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Measles virus glycoproteins: studies on the structure and interaction of the haemagglutinin and fusion proteins.

Authors:  E Malvoisin; T F Wild
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

10.  Characterization of a region involved in binding of measles virus H protein and its receptor SLAM (CD150).

Authors:  Chunling Hu; Peng Zhang; Xin Liu; Yipeng Qi; Tingting Zou; Qin Xu
Journal:  Biochem Biophys Res Commun       Date:  2004-04-09       Impact factor: 3.575

View more
  59 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  C-terminal tyrosine residues modulate the fusion activity of the Hendra virus fusion protein.

Authors:  Andreea Popa; Cara Teresia Pager; Rebecca Ellis Dutch
Journal:  Biochemistry       Date:  2011-01-20       Impact factor: 3.162

3.  Type II integral membrane protein, TM of J paramyxovirus promotes cell-to-cell fusion.

Authors:  Zhuo Li; Cher Hung; Reay G Paterson; Frank Michel; Sandra Fuentes; Ryan Place; Yuan Lin; Robert J Hogan; Robert A Lamb; Biao He
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

4.  Paramyxoviruses: different receptors - different mechanisms of fusion.

Authors:  Ronald M Iorio; Paul J Mahon
Journal:  Trends Microbiol       Date:  2008-03-17       Impact factor: 17.079

5.  A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.

Authors:  Katharine N Bossart; Thomas W Geisbert; Heinz Feldmann; Zhongyu Zhu; Friederike Feldmann; Joan B Geisbert; Lianying Yan; Yan-Ru Feng; Doug Brining; Dana Scott; Yanping Wang; Antony S Dimitrov; Julie Callison; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Christopher C Broder; Barry Rockx
Journal:  Sci Transl Med       Date:  2011-10-19       Impact factor: 17.956

6.  Differential rates of protein folding and cellular trafficking for the Hendra virus F and G proteins: implications for F-G complex formation.

Authors:  Shannon D Whitman; Everett Clinton Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

7.  Stimulation of Nipah Fusion: Small Intradomain Changes Trigger Extensive Interdomain Rearrangements.

Authors:  Priyanka Dutta; Ahnaf Siddiqui; Mohsen Botlani; Sameer Varma
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

8.  A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.

Authors:  Chad E Mire; Joan B Geisbert; Krystle N Agans; Yan-Ru Feng; Karla A Fenton; Katharine N Bossart; Lianying Yan; Yee-Peng Chan; Christopher C Broder; Thomas W Geisbert
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.

Authors:  Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Andrew C Hickey; Mark A Smith; Yee-Peng Chan; Lin-Fa Wang; Joseph J Mattapallil; Joan B Geisbert; Katharine N Bossart; Christopher C Broder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

10.  A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Authors:  Katharine N Bossart; Zhongyu Zhu; Deborah Middleton; Jessica Klippel; Gary Crameri; John Bingham; Jennifer A McEachern; Diane Green; Timothy J Hancock; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Lin-Fa Wang; Christopher C Broder
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.